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Abstract
Psoriasis is a chronic inflammatory disease involving about 2–3% of the Norwegian
population. Sun exposure has a positive effect on most psoriasis lesions, but ultraviolet
(UV) radiation also causes a direct DNA damage in the skin cells and comprises a
carcinogenic potential. UV exposure on the skin causes a local as well as a systemic5
immune suppressive effect, but the relation between sun exposure and these biological
effects is not well known. In March 2006 a study was carried out to investigate possible
therapeutic outcome mechanisms in 20 psoriasis patients receiving climate therapy at
Gran Canaria. This paper presents estimates of their individual skin UV-doses based
on UV measurements and the patients’ diaries with information on time spent in the10
sun.
On the first day of exposure the patients received on average 5.1 Standard Erythema
Doses (SED: median=4.0 SED, range 2.6–10.3SED) estimated to the skin. During the
15 days study they received 165.8SED (range 104.3–210.1SED). The reduction in
PASI score was 72.8% on average, but there was no obvious relation between the15
improvement and the UV dose. The UV doses were higher than those found from cli-
mate therapy studies at other locations. It seems beneficial to use more strict exposure
schedules that consider the available UV irradiance, depending on time of the day, time
of the year and weather conditions.
1 Introduction20
Psoriasis is a chronic inflammatory disease involving about 2–3% of the Norwegian
population. Plaque psoriasis, the most common form of psoriasis, typically appears
as raised areas of inflamed skin covered with silvery white scaly skin. The severity
is usually graded as mild, moderate or severe. The Psoriasis Area Severity Index
(PASI) is the most widely used measurement tool for psoriasis. The PASI score varies25
from 0 (no symptoms) to a maximum of 72, reflecting the surface area affected and
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the severity of the lesions, i.e. the redness, thickness and scaling (Fredriksson and
Pettersson, 1978).
Ultraviolet (UV) radiation from the sun is an effective and natural treatment method
for psoriasis. The cell proliferation in the basal layer of the skin is increased in the
psoriasis lesions and the UV radiation slows down this process. Furthermore, the5
combination of UVB-induced apoptosis, increased secretion of anti-inflammatory cy-
tokines and decreased trafficking to the skin, may also explain the beneficial effects of
UVB treatment on psoriasis and why disease remission can sometimes be sustained
for a prolonged period (Sigmundsdottir et al., 2003, 2005). Climate therapy has been
offered to psoriasis patients since many years at low latitude locations such as in the10
Dead Sea resort and the Canary Islands, and at high altitude locations, e.g. in Davos,
Switzerland. Norwegian psoriasis patients have been offered climate therapy since
late 1976 (NOU, 2000). Today, this treatment option is administrated by the Section for
Climatotherapy, Department of Reumatology at the Rikshospitalet University Hospital
in Oslo, Norway. The patients are treated at the Norwegian Health Centre at Valle Ma-15
rina, Gran Canaria, for 3 weeks in the period January to June and September to the
beginning of December. The therapy is supervised by a resident dermatologist, nurses
and physiotherapists. It focuses on UV exposure paralleled by educational courses
designed to help the patients in coping with the chronic aspects of psoriasis and to
highlight the importance of diet and physical activity.20
The original schedule for the 28 day Dead Sea climate therapy of psoriasis called for
a sun exposure of 6–7 h daily, following shorter acclimatization sessions during the first
week (Abels and Rose, 1995). However, recent studies from the Dead Sea area have
reported 69.7–86% improvement with respect to PASI score in patients receiving only
3 h daily sun exposure (excluding the noon hours) for 4 weeks in the period March to25
November (Even-Paz et al., 1996 and Even-Paz and Efron, 2003). They monitored the
ambient UV dose in terms of Standard Erythema Dose (SED), and these results were
achieved for ambient UV doses higher than 170SED. Treatment in December with an
ambient dose of 120SED showed only 33% improvement.
3
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Other studies have also estimated or measured UV doses in relation to regular cli-
mate therapy. Vocks et al. (1989) found a mean UVB dose of 1.04 J/cm
2
(50 Minimal
Erythema Doses, MED) for a 6 weeks high altitude treatment in Davos, Switzerland.
Kushelevsky et al. (1998) found a mean ambient UV dose of 3.11 J/cm
2
or 148MED for
skin type IV patients after 4 weeks treatment by the Dead Sea. Snellman et al. (1992)5
found from personal dosimeters a mean ambient dose of about 3.3 J/cm
2
after a 4 week
treatment and on average about 1.3 J/cm
2
to the skin.
This paper will present estimated UV doses for the psoriasis patients participating in
a study to investigate the influence of the sun exposure on local and systemic immuno-
logic effects. In particular, cytokines, T cell profiles, vitamin D and its metabolites were10
investigated. This report focuses specifically on the measurements of UV radiation that
underlies the expected changes in the biological mechanisms.
2 Material and methods
The study was carried out in March 2006 at the Norwegian Health Centre at Valle
Marina, Gran Canaria (27
◦
N, 15
◦
W). Climate therapy for psoriasis patients lasts for 2115
days. The study period lasted for 15 of these 21 days, starting at 15 March 2006.
2.1 Patient material
The study included 20 patients (mean age 47.2 years, range 24–65, 6 females and
14 males) with moderate to severe psoriasis. PASI before climate therapy was 9.8
(mean, range 3.8–18.8). PASI scores were assessed by dermatologists before and20
after the sun exposure. The patients had stopped using any psoriasis medication 4
weeks before the study started. Two of the patients had skin type II and 18 had skin
type III according to the Fitzpatrick classification (Fitzpatrick, 1988).
Blood samples and skin biopsies were taken before the sun exposure, after one day
and after 15 days of exposure.25
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The patients followed a strict exposure schedule the first day of the study, exposing
first the front side of the body for 30min, the back side for 30min, followed by 15min
exposure on each side in the period from about 11:00 and 13:00 LT. They were allowed
to stay outside after lunch, but only if a proper amount (2mg/cm
2
) of sunscreen with sun
protection factor (SPF) of 25 (Pediatrics Fotoprotector ISDN, 25B-10A-IR) was used for5
the whole body (Colipa, 2006). For the remaining days, the patients were advised to
gradually increase the hours of exposure per day and only use sunscreen on locations
easily burned. The patients registered time spent in the sun every day and for every
20min interval from 09:00 to 17:00 LT, as well as use of sunscreen and type of SPF
factor.10
2.2 UV measurements
Spectral UVB (280–315 nm), UVA (315–400 nm) and CIE-weighted UV irradiances
were measured using two broadband instruments every hour from 09:00 to 17:00 LT ev-
ery day from 15 to 29 March 2006. The CIE-action spectrum is a reference action spec-
trum for UV induced erythema in Caucasian human skin (McKinlay and Diffey, 1987)15
valid for the UV region from 250 to 400 nm. One of the broadband radiometers (Solar
Light Co PMA 2100) was used with two sensors, one (PMA 2101 UVB sensor) that
roughly resembles the spectral responsivity of the CIE-action spectrum, and the other
(PMA 2110 UVA sensor) with fairly flat spectral responsivity in the UVA waveband.
The other broadband instrument (Gigahertz-Optik GmbH X1 1 Optometer) was used20
with UVB and UVA sensors (XD-9501-4) both with fairly flat responsitivities. The Solar
Light PMA sensors were calibrated against a spectroradiometer (Brewer#185, mea-
surement range 286.5–365 nm, extended for UVA 365–400 nm) at Izan˜a, Tenerife, prior
to the study. Measurements and calibration factors were provided by Mr. Alberto Re-
dondas, Instituto Nacional de Meteorologia (INM), Spain. The spectroradiometer was25
calibrated in February 2005 and compared with the QUASUME Unit (Quality Assurance
of Spectral Ultraviolet Measurements in Europe, http://lap.physics.auth.gr/qasume/) in
September 2005. The Gigahertz-Optik sensor readings were compared with those of
5
ACPD
8, 1–19, 2008
UV doses during
psoriasis climate
therapy at Gran
Canaria
L. T. N. Nilsen et al.
Title Page
Abstract Introduction
Conclusions References
Tables Figures
◭ ◮
◭ ◮
Back Close
Full Screen / Esc
Printer-friendly Version
Interactive Discussion
EGU
the Solar Light sensors.
2.3 UV dose estimates
Spectral UVB and UVA irradiances, in addition to CIE-weighted UVB and UVA irradi-
ances, were calculated for the whole period using a radiation transfer model, libRadtran
for irradiance calculations (Mayer and Kylling, 2005). The model was run for the fol-5
lowing conditions: cloudless sky, albedo of 0.05, sea level and ozone values from the
TOMS satellite for the days 15 to 29 March 2006 (NASA, 2006).
The UV irradiances were adjusted according to the measurements taken at Valle
Marina to account for the real weather situation and possible discrepancies from the
model parameters, such as different albedo and aerosol amount.10
Combining the calculated UV irradiances with the sun exposure time from the pa-
tients’ diaries, UV doses were estimated for each patient after 1 day and after 15 days
of sun exposure (according to when the blood samples and skin biopsies were taken
as described in Sect. 2.1). Exposure times were calculated, on one hand, including
all reported sun exposure, also when sunscreen was used. On the other hand, the15
exposure time using sunscreen the first day was excluded.
3 Results
The results are presented as spectral UVB and UVA doses, as well as CIE-weighted
UVB, UVA and UV doses. Standard Erythema Dose (SED) is also presented
(1SED=100 J/m
2
=0.01 J/cm
2
). All results are presented as mean of the doses as well20
as the range of doses (minimum-maximum). Median doses are presented when data
are skewed. UV doses to each patient are set equal to the ambient UV doses divided
by two, since only half the body can be exposed at any time. Doses are presented for
the two cases; including and excluding exposure time when sunscreen was used the
first day.25
6
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Sun exposure time each day and for each patient (Fig. 1) shows roughly a gradual
increase throughout the treatment period, except for day 2 when all patients went by
bus to and from the hospital in Las Palmas for taking blood samples and biopsies.
When exposure using sunscreen the first day was excluded, the exposure time was
2.0/1.7 h (mean/median, range 1.0–4.0 h), whereas the corresponding number when5
sun exposure with sunscreen was included, was 3.6/3.7 h (range 2.0–5.0).
Table 1 shows the estimated UV doses to the skin after 1 day of sun exposure, both
inclusive and exclusive time when using sunscreen. The patients sunbathing with sun-
screen during the first day reported using approximately 30ml of cream. The estimated
UV doses for sun exposure when sunscreen effect was excluded varied between 2.610
and 10.3SED and with a mean and median dose of 5.1 and 4.0SED, respectively
(Table 1 and Fig. 2). The mean dose was the same for the patients with skin type II
and III. Seven patients exposed themselves to the sun without the prescribed sun-
screen after lunch the first day and thereby received higher UV doses (Fig. 2). The po-
tential doses were markedly higher when time with sunscreen was included (Table 1).15
Fourteen out of the 20 patients reported erythema after the first day of sun exposure.
The mean dose after 15 days sun exposure was 165.8SED if sunscreen use the
first day was excluded (Table 2), 134.5 and 169.2SED for the patients with skin type II
and III, respectively. If sunscreen use the first day was included, the mean dose was
169.6SED for all subjects combined. The patients reported using sunscreen mostly on20
body sites that could easily be burned, and the amount of sunscreen varied between
30 and 700ml. The variation between minimum and maximum patient doses each day
was large (Fig. 3). For the whole treatment period the accumulated doses varied by a
factor 2 (Table 2 and Fig. 2).
All patients experienced a reduction in PASI score after the climate therapy to an25
average score of 2.4, range 0.4–6.9. This can be expressed as a mean 72.8% (median
77.8%, range 30.3–92.6%) improvement in PASI score. The percentage improvement
did not show significant correlation to the UV dose received by each patient (Fig. 4).
7
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4 Discussion and conclusions
UV doses have been estimated for psoriasis patients receiving climate therapy at Gran
Canaria in March 2006. The doses were estimated using a radiative transfer model
corrected for local influence using broadband instruments positioned at the Norwegian
Health Centre at Valle Marina. The UV doses were combined with sun exposure times5
registered by the patients each day.
When estimating UV doses, it is important to either measure UV irradiances on the
actual location or use a simulation model with real weather conditions. These must be
combined with indications of the time when patients have been exposed to the sun.
On day 3, 8, 13 and 14 of this study, the patients spent relatively much time in the10
sun (Fig. 1), but the UV doses on these days were low (Fig. 3). The reason was more
cloudy weather conditions and thereby lower UV intensities these days. Even though
the patients were told to register all exposure time, the use of diaries is associated with
uncertainties regarding registration of exposure time, e.g. whether 5–10min walk to
and from the nearest beach is included or not.15
The assumption that the UV dose to the skin equals half the ambient dose is cru-
cial. Different body sites have been shown to receive different proportions of UV, also
depending on type of activity. Snellman et al. (1992) showed from personal dosime-
ter measurements that different body sites of psoriasis patients received from 22.2%
(part of abdomen) up to 63.3% (upper arm) of the ambient UV dose, with an average20
of 41.2% for all sites. Diffey et al. (1982) showed that sunbathing on the beach gave
80% of the ambient UV dose, while sight seeing only gave 17%. Thieden et al. (2000)
have shown that different body sites received 29–86% of the ambient dose when stay-
ing at a Danish beach with the highest doses on the shoulders. On average, the wrist
received about half the ambient dose both at the beach and during holiday season in25
Scandinavia and Europe. Therefore, the assumption that our patients received half the
ambient dose on each skin site seems to be appropriate as a first approximation.
Use of sunscreen also influences the UV exposure to the skin. The declared SPF fac-
8
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tor requires application of the sunscreen with a thickness of 2mg/cm
2
(Colipa, 2006).
For an adult body that would be about 40 ml (Siekmann and Aengenvoort, 2007). Most
of our patients used almost this amount after lunch the first day of sun exposure. The
doses after one day of exposure shown in Table 1, excluding exposure time with sun-
screen, correspond well with the fact that 14 patients reported erythema. Though, no5
blistering erythema was reported. Harrison and Young (2002) indicated moderate sun-
burn to occur for doses of 5–8SED and painful, blistering sunburn at 10SED, for most
white skin. For the remaining days with sun exposure, the patients spent varying de-
gree and generally small amounts of sunscreen. They were asked to avoid sunscreen
on the psoriasis lesions. To use all exposure time would therefore be reasonable when10
estimating the UV doses to the lesions. Furthermore, the body sites where the patients
reported to have used sunscreen, were those susceptible to be sunburned. These sites
were probably those receiving more than 50% of the available UV (Snellman, 1992 and
Thieden, 2000).
The cumulative UV doses in Table 2 were estimated for the 15 days of sun exposure,15
whereas a regular treatment lasts for 21 days. The patients reached a plateau of daily
sun exposure after the first week. Doses for a 3weeks treatment period can therefore
be estimated adding 6 days of exposure from the average of the last 5 days (day 11–
15). This would give a mean UV dose to the skin for 3 weeks treatment, starting in
March, of 253SED (2.53 J/cm
2
) or an ambient dose of 506SED (5.06 J/cm
2
). These20
doses are higher than those found by Snellman et al. (1992) for a 4 weeks treatment at
the Canary Island in November 1989 (on average a skin dose of about 1.3 J/cm
2
), and
Vocks et al. (1989) for a 6 weeks treatment in Davos (ambient UVB dose of 1.4 J/cm
2
).
The doses are also higher than those found at the Dead Sea (ambient dose 170–
390 SED or 1.70–3.90 J/cm
2
) exposing the patients for only 3 h per day for 4 weeks25
(Even-Paz et al., 1996 and Even-Paz and Efron, 2003).
Interestingly, the psoriasis patients at Valle Marina seem to achieve good improve-
ment also for other periods of the year, and with approximately the same sun exposure
time. Figure 5 shows estimated doses for other time periods of the year when patients
9
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are sent to Valle Marina. It shows a factor 3 difference in UV dose between January
and June. Patients treated in June may therefore receive higher doses than needed to
achieve good therapeutic improvement.
Broadband UVB light therapy is given at the Rikshospitalet University Hospital in
Oslo. The CIE-weighted UVB dose used for skin type III is 0.03–0.05 J/cm
2
for the first5
exposure. The corresponding dose for the climate therapy patients the first day was in
the same range as in the clinic, with a few patients receiving higher doses (Table 1).
The UV dose to the skin during a 3 weeks climate therapy (253SED) is higher than
the doses typically received by Danes during the whole year, estimated from personal
dosimeter measurements by Thieden et al. (2004) (median 173 SED, range 132SED10
for indoor workers – 224SED for gardeners). Sunbathing on the beach in Southern
Europe showed just as high UV doses as for our patients (median 6.9SED per day,
range 0.4–32.6SED per day).
In conclusion, 3 weeks climate therapy at Gran Canaria resulted in 73% reduction in
PASI score. Estimated mean UV dose to the skin for the 15 days sun exposure was15
165.8SED. The individual percentual reduction in PASI score did not seem to depend
on the UV dose. UV doses to our patients are higher than those received by climate
therapy patients at other locations, in particular in May and June. It seems benefi-
cial to use more strict exposure schedules that consider the available UV irradiance,
depending on time of the day, time of the year and weather conditions.20
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Table 1. Estimated UV doses to the patients after 1 day of sun exposure. Note: the values
correspond to the respective ambient doses divided by 2.
UV doses [J/cm
2
] after 1 day of exposure
Sun exposure when time with sunscreen:
is included is excluded
UVB Mean 0.64 0.36
Range 0.36–0.88 0.19–0.72
UVA Mean 26.7 14.9
Range 15.0–36.7 7.6–29.7
CIE-weighted UVB Mean 0.073 0.042
Range 0.040–0.100 0.021–0.083
CIE-weighted UVA Mean 0.018 0.010
Range 0.010–0.024 0.005–0.020
CIE-weighted UV Mean 0.090 0.051
Range 0.050–0.124 0.026–0.103
Dose, SED Mean 9.0 5.1
Range 5.0–12.4 2.6–10.3
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Table 2. Estimated cumulative UV doses received by the patients after 15 days of exposure.
Note: the values correspond to the respective ambient doses divided by 2.
UV doses [J/cm
2
] after 15 day of exposure
Sun exposure when time with sunscreen:
is included is excluded at day 1
UVB Mean 11.8 11.5
Range 7.4–14.6 7.2–14.6
UVA Mean 464.2 452.4
Range 281.3–579.7 273.6–579.7
CIE-weighted UVB Mean 1.390 1.359
Range 0.884–1.723 0.862–1.723
CIE-weighted UVA Mean 0.306 0.298
Range 0.186–0.382 0.181–0.382
CIE-weighted UV Mean 1.696 1.658
Range 1.069–2.101 1.043–2.101
Dose, SED Mean 169.6 165.8
Range 107.0–210.1 104.3–210.1
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Fig. 1. Sun exposure time for each patient and for each day. The daily average duration is
shown as the black line. The exposure times corrected for the use of sunscreen on day 1 are
indicated by a rectangle.
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 Fig. 2. UV doses estimated for each patient on the first day of sun exposure (black circles, left
axis) and for the whole period of sun exposure (day 1 to 15; red squares, right axis). The doses
correspond to the ambient doses divided by 2.
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Fig. 3. UV doses estimated for each patient for each day. The doses correspond to the ambient
doses divided by 2. The rectangle marking the data points before day 1 indicates the doses
excluding exposure time under the application of sunscreen.
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Fig. 4. The cumulative UV dose did not show relation to the percentage improvement in PASI
score.
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Fig. 5. Estimated UV doses for a full treatment period of 21 days depending on the time of the
year. The doses are estimated using the sun exposure schedule, weather conditions and ozone
values as for the study in March 2006. Doses are calculated as the ambient doses divided by
2.
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